{{Infobox company
  |name = 赛诺菲健赞<br>Sanofi Genzyme
  |image=Genzyme building.jpg
  |caption= 赛诺菲健赞总部，[[剑桥_(马萨诸塞州)|剑桥 (马萨诸塞州)]]
  | logo = Genzyme logo.svg
  | type = 全资子公司
  | foundation = [[波士顿|波士顿]] (1981)
  | location_city = [[马萨诸塞州|马萨诸塞州]][[剑桥_(马萨诸塞州)|剑桥]]
  | location_country ={{USA}}
  | key_people = David Meeker, MD
  | industry = [[生物技术|生物技术]]
  | products = Cerezyme<br />Fabrazyme<br />Synvisc<br />Renagel<br />
  | revenue = [[United_States_dollar|US $]]4.61 [[1000000000_(number)|billion]] (2007 calendar)<ref name="2007financials">
    {{cite web
      | author = Yahoo!Finance
      | url = https://finance.yahoo.com/q/is?s=GENZ&annual
      | title = Income Statement for Genzyme
      | publisher = Yahoo!
      | accessdate = March 16, 2007
    }}</ref>
  | operating_income = {{profit}}[[United_States_dollar|US $]]581 [[1000000_(number)|million]] (2007 calendar)<ref name="2007financials" />
  | net_income = {{profit}}[[United_States_dollar|US $]]421 [[1000000_(number)|million]] (2007 calendar)<ref name="2007financials" />
  | num_employees = 12,000 (2010)
  | parent = [[赛诺菲|赛诺菲]]
  | homepage = {{url|http://www.sanofigenzyme.com|sanofigenzyme.com}}
}}
'''赛诺菲健赞'''({{lang-en|Sanofi Genzyme}})是一家位于美国[[马萨诸塞州|马萨诸塞州]][[剑桥_(马萨诸塞州)|剑桥]]的生物技术公司。

==历史==
1981年由[[乔治·怀特塞兹|乔治·怀特塞兹]]和[[谢里登·斯奈德|谢里登·斯奈德]]在美国[[波士顿|波士顿]]成立。[[亨利·泰梅尔|亨利·泰梅尔]]1983年加入成为公司总裁，正是这段时间公司估值达到1亿美元。1985年成为公司[[首席执行官|首席执行官]]，1986年公司在[[纳斯达克|纳斯达克]]上市，公司致力于[[孤儿药|孤儿药]]和[[高雪氏症|高雪氏症]]的疗效制药，在2010年健赞在全球雇用超过11000人，是全球第三大生物技术公司。目前健赞已经分布在五大洲六十五个国家地区，拥有17个制造车间和9个遗传测试实验室，并销售到全球90多个国家。<ref>{{cite web |url=http://www.uspto.gov/nmti/recipients_05.html |title=The National Medal of Technology Recipients 2005 Laureates |accessdate=February 26, 2009 |date=February 19, 2009 |work=The National Medal of Technology and Innovation |publisher=United States Patent and Trademark Office}}</ref>

==收购出价==
2010年8月30日，[[赛诺菲|赛诺菲]]宣布以18.5亿美元收购健赞，该交易后来被其董事会拒绝。2011年2月16日，赛诺菲又以201亿美元全面收购健赞。<ref name="Sanofi_2011">{{cite news| url=https://www.reuters.com/article/2011/02/03/uk-sanofi-genzyme-idUKTRE7121P720110203 | work=Reuters | title=Sanofi could announce Genzyme deal next week – report | date=February 3, 2011 | first=James | last=Regan}}</ref>

==参考来源==
{{reflist}}

==外部链接==
* Schouten, E. "Genzyme’s lifelong commitments". NRC Handelsblad. November 24, 2005.
* https://web.archive.org/web/20060924143610/http://www.gaucher.org.uk/cercer.htm
* Hirehealth’s website (https://web.archive.org/web/20061029102247/http://www.hirehealth.com/Public/CompanyDetails.aspx?COMPANY_ID=44719)
* Riskind. P. Multiple Sclerosis—The immune system’s terrible mistake. Fall 1996, Vo. 5, No. 4.
* Hoovers’ website (http://www.hoovers.com/genzyme/--ID__13560--/free-co-factsheet.xhtml)
* Calabro, S. "Genzyme put patients first, and grew to become a multi-billion-dollar company. But empires don't survive on altruism." Pharmaceutical Executive, [March 1, 2006] (http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=310976&&pageID=7&searchString=genzyme)
*[http://www.genzyme.com Genzyme corporate website]
*[http://www.opensecrets.org/lobby/clientsum.php?lname=Genzyme+Corp&year=2009 Center for Responsive Politics profile]

[[Category:赛诺菲|Category:赛诺菲]]
[[Category:美国生物技术公司|Category:美国生物技术公司]]
[[Category:纳斯达克已除牌公司|Category:纳斯达克已除牌公司]]
[[Category:马萨诸塞州公司|Category:马萨诸塞州公司]]
[[Category:罕用药|Category:罕用药]]
[[Category:1981年成立的公司|Category:1981年成立的公司]]